메뉴 건너뛰기




Volumn 9, Issue 2, 2000, Pages 150-153

Cost analysis of glaucoma medications

Author keywords

Cost; Glaucoma; Medications; Treatment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIGLAUCOMA AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BETOPTIC S; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; LATANOPROST; LEVOBUNOLOL; PROSTAGLANDIN DERIVATIVE; TIMOLOL MALEATE;

EID: 0034449668     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/00061198-200004000-00004     Document Type: Article
Times cited : (21)

References (14)
  • 1
    • 0031601658 scopus 로고    scopus 로고
    • National health spending trends in 1996
    • Levit K, Lazenby H, Braden B, and the National Health Accounts Team. National health spending trends in 1996. Health Aff 1998: 17:35-51.
    • (1998) Health Aff , vol.17 , pp. 35-51
    • Levit, K.1    Lazenby, H.2    Braden, B.3
  • 2
    • 2642685027 scopus 로고    scopus 로고
    • Notes on current labor statistics: Price data
    • Washington, DC; US Government Printing Office
    • US Department of Labor. Notes on current labor statistics: price data. Monthly Labor Review 120. No. 1. Washington, DC; US Government Printing Office. 1997.
    • (1997) Monthly Labor Review 120 , vol.1
  • 3
    • 0031910689 scopus 로고    scopus 로고
    • Projecting future drug expenditures - 1998
    • Mehl B, Santell J. Projecting future drug expenditures - 1998. Am J Health Syst Pharm 1998;55:127-135.
    • (1998) Am J Health Syst Pharm , vol.55 , pp. 127-135
    • Mehl, B.1    Santell, J.2
  • 4
    • 0002377305 scopus 로고    scopus 로고
    • Some HMOs now put doctors on a budget for prescription drugs
    • May 22
    • Johannes L. Some HMOs now put doctors on a budget for prescription drugs. Wall Street Journal. May 22, 1997:A1, A6.
    • (1997) Wall Street Journal
    • Johannes, L.1
  • 5
    • 1642506056 scopus 로고    scopus 로고
    • Worldwide ophthalmic drug sales projected to reach $3.18 billion in 1996 vs $3 billion in 1995
    • Philadelphia: Dorland's Biomedical
    • Worldwide ophthalmic drug sales projected to reach $3.18 billion in 1996 vs $3 billion in 1995. Medical & Health Care Marketplace Guide. 12th ed. Philadelphia: Dorland's Biomedical, 1996:169.
    • (1996) Medical & Health Care Marketplace Guide. 12th Ed. , pp. 169
  • 6
    • 1642506054 scopus 로고    scopus 로고
    • Pharmacia & Upjohn Inc's Xalatan ophthalmic product generated sales of $65 million in 1996; to reach S115 million by 1997
    • Pharmacia & Upjohn Inc's Xalatan ophthalmic product generated sales of $65 million in 1996; to reach S115 million by 1997. R&D Directions 1997;2:41.
    • (1997) R&D Directions , vol.2 , pp. 41
  • 7
    • 1642465301 scopus 로고    scopus 로고
    • Selective alpha-2 agonist for treatment of glaucoma aimed at market estimated at $1 billion
    • Selective alpha-2 agonist for treatment of glaucoma aimed at market estimated at $1 billion. PharmaBusiness 1998;20;82.
    • (1998) PharmaBusiness , vol.20 , pp. 82
  • 8
    • 1642546856 scopus 로고    scopus 로고
    • The worldwide glaucoma market is worth $1 billion and may rise 7.5% per year
    • The worldwide glaucoma market is worth $1 billion and may rise 7.5% per year. PharmaBusiness 1997;16:77.
    • (1997) PharmaBusiness , vol.16 , pp. 77
  • 9
    • 0000832785 scopus 로고    scopus 로고
    • Quantitative and cost evaluation of three antiglaucoma beta-blocker agents: Timoptic-XE versus two generic levobunolol products
    • Hartenbaum D, et al. Quantitative and cost evaluation of three antiglaucoma beta-blocker agents: Timoptic-XE versus two generic levobunolol products. Am J Managed Care 1996;2:157-162.
    • (1996) Am J Managed Care , vol.2 , pp. 157-162
    • Hartenbaum, D.1
  • 10
    • 0024579844 scopus 로고
    • Comparison of timolol maleate and levobunolol: Doses and volume per bottle
    • Schwartz J. Christensen R, Lee D. Comparison of timolol maleate and levobunolol: doses and volume per bottle. Arch Ophthalmol 1989;107:17-18.
    • (1989) Arch Ophthalmol , vol.107 , pp. 17-18
    • Schwartz, J.1    Christensen, R.2    Lee, D.3
  • 11
    • 0022512760 scopus 로고
    • Drop size of commercial glaucoma medications
    • Lederer C, Harold R. Drop size of commercial glaucoma medications. Am J Ophthalmol 1986;101:691-694.
    • (1986) Am J Ophthalmol , vol.101 , pp. 691-694
    • Lederer, C.1    Harold, R.2
  • 13
    • 0026728953 scopus 로고
    • Cost of beta-adrenergic receptor blocking agents for ocular hypertension
    • Schreider E, Ball S. Cost of beta-adrenergic receptor blocking agents for ocular hypertension. Arch Ophthalmol 1992;110:654-657.
    • (1992) Arch Ophthalmol , vol.110 , pp. 654-657
    • Schreider, E.1    Ball, S.2
  • 14
    • 0032005245 scopus 로고    scopus 로고
    • Costs of glaucoma medications
    • Fiscella R. Costs of glaucoma medications. Am J Health Syst Pharm 1998;55:272-275.
    • (1998) Am J Health Syst Pharm , vol.55 , pp. 272-275
    • Fiscella, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.